Acute Myeloid Leukemia (AML)

  • Trial ID: AML003 | NCT03504410
  • Last Updated: 26 May, 2021

Clinical Trial AML003: Older Patients with Acute Myeloid Leukemia (AML) – Relapsed or Refractory

The purpose of this study is to evaluate the efficacy and safety of CHAM versus HAM.

  • 47 Sites

For Patients

Get information about indications and participating in clinical trials that match your diagnoses.

More Info

For Physicians

Learn about treatments and read the latest news and resources for health professionals.

More Info

Have questions? Live support is available 24/7 - Call (609) 409 7050 or Email Us